Andreas Pinter
Goethe University Frankfurt(DE)University Hospital Frankfurt(DE)Hidradenitis Suppurativa Foundation(US)
Publications by Year
Research Areas
Psoriasis: Treatment and Pathogenesis, Dermatology and Skin Diseases, Asthma and respiratory diseases, Pharmaceutical studies and practices, Health Systems, Economic Evaluations, Quality of Life
Most-Cited Works
- → An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma(2020)972 cited
- → Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate to severe plaque psoriasis: CLEAR, a randomized controlled trial(2015)538 cited
- → Development and validation of the International Hidradenitis Suppurativa Severity Score System ( IHS 4), a novel dynamic scoring system to assess HS severity(2017)436 cited
- → Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1 year: Results from the CLEAR study(2016)302 cited
- → Bimekizumab efficacy and safety in moderate to severe plaque psoriasis (BE READY): a multicentre, double-blind, placebo-controlled, randomised withdrawal phase 3 trial(2021)268 cited
- → Phase 2B randomized study of nemolizumab in adults with moderate-to-severe atopic dermatitis and severe pruritus